Volatility in US pharmaceutical and healthcare markets has produced mixed results for long/short managers trading equities in this sector. A combination of political and regulatory wranglings over drug manufacturing is being blamed for price movements.
In addition, energy stocks including crude oil are being overvalued as a result of stockpiling in response to the threat of war, as Mike Ward, portfolio manager for the $100m Franklin Templeton US Registered long/short fund, explains. 'We have m
The week on Risk.net, December 9–15 2017Receive this by email